Methylene blue potentiates stimulus-evoked fMRI responses and cerebral oxygen consumption during normoxia and hypoxia

NeuroImage

Volumn 72, Issue , 2013, Pages 237-242

  Huang, Shiliang ^a   Du, Fang ^a   Shih, Yen Yu I ^a   Shen, Qiang ^a   Gonzalez Lima, F ^b   Duong, Timothy Q ^a,c  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^c SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

Author keywords

Arterial spin labeling; BOLD; CBF; Cerebral metabolic rate of oxygen; FMRI; Forepaw stimulation; Oxidative metabolism; Perfusion

Indexed keywords

METHYLENE BLUE;

ANIMAL EXPERIMENT; ARTERIAL OXYGEN SATURATION; ARTICLE; BOLD SIGNAL; BRAIN BLOOD FLOW; BRAIN HEMODYNAMICS; BRAIN METABOLISM; BRAIN OXYGEN CONSUMPTION; CONTROLLED STUDY; DISEASE SEVERITY; EVOKED RESPONSE; FOREFOOT; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HEART RATE; HEMODYNAMICS; HYPERCAPNIA; HYPOXIA; IN VIVO STUDY; INHALATION; MALE; METABOLIC RATE; METABOLIC STRESS; NERVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; RAT; STIMULUS RESPONSE;

ANIMALS; ANOXIA; ANTIOXIDANTS; BRAIN; CEREBROVASCULAR CIRCULATION; HEMODYNAMICS; MAGNETIC RESONANCE IMAGING; MALE; METHYLENE BLUE; OXYGEN CONSUMPTION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84874514259     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2013.01.027     Document Type: Article

References (46)

1. Bandettini P.A., Wong E.C., Hinks R.S., Rikofsky R.S., Hyde J.S. Time course EPI of human brain function during task activation. Magn. Reson. Med. 1992, 25:390-397.
2. Bardutzky J., Shen Q., Henninger N., Bouley J., Duong T.Q., Fisher M. Differences in ischemic lesion evolution in different rat strains using diffusion and perfusion imaging. Stroke 2005, 36:2000-2005.
3. Boxerman J.L., Bandettini P.A., Kwong K.K., Baker J.R., Davis T.L., Rosen B.R., Weisskoff R.M. The intravascular contribution to fMRI signal change: Monte Carlo modeling and diffusion-weighted studies in vivo. Magn. Reson. Med. 1995, 34:4-10.
4. Bruchey A.K., Gonzalez-Lima F. Behavioral, physiological and biochemical hormetic responses to the autoxidizable dye methylene blue. Am. J. Pharmacol. Toxicol. 2008, 3:72-79.
5. Clifton J., Leikin J.B. Methylene blue. Am. J. Ther. 2003, 10:289-291.
6. Davis T.L., Kwong K.K., Weisskoff R.M., Rosen B.R. Calibrated functional MRI: mapping the dynamics of oxidative metabolism. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:1834-1839.
7. Detre J.A., Leigh J.S., Williams D.S., Koretsky A.P. Perfusion imaging. Magn. Reson. Med. 1992, 23:37-45.
8. Duong T.Q., Silva A.C., Lee S.P., Kim S.G. Functional MRI of calcium-dependent synaptic activity: cross correlation with CBF and BOLD measurements. Magn. Reson. Med. 2000, 43:383-392.
9. Duong T.Q. Cerebral blood flow and BOLD fMRI responses to hypoxia in awake and anesthetized rats. Brain Res 2007, 1135:186-194.
10. Gonzalez-Lima F., Bruchey A.K. Extinction memory improvement by the metabolic enhancer methylene blue. Learn. Mem. 2004, 11:633-640.
11. 2 on cerebral blood volume, blood flow, and vascular mean transit time. Stroke 1974, 5:630-639.
12. Ishiwata A., Sakayori O., Minoshima S., Mizumura S., Kitamura S., Katayama Y. Preclinical evidence of Alzheimer changes in progressive mild cognitive impairment: a qualitative and quantitative SPECT study. Acta Neurol. Scand. 2006, 114:91-96.
13. Juffermans N.P., Vervloet M.G., Daemen-Gubbels C.R., Binnekade J.M., de Jong M., Groeneveld A.B. A dose-finding study of methylene blue to inhibit nitric oxide actions in the hemodynamics of human septic shock. Nitric Oxide 2010, 22:275-280.
14. Kwong K., Hoppel B., Weisskoff R., Kiihne S., Barrere B., Moore J., Poncelet B., Rosen B., Thulborn K. Regional cerebral tissue oxygenation studied with EPI at clinical field strengths. J. Magn. Reson. Imaging 1992, 2:44.
15. Lee R.B., Urban J.P. Functional replacement of oxygen by other oxidants in articular cartilage. Arthritis Rheum. 2002, 46:3190-3200.
16. Lindahl P.E., Oberg K.E. The effect of rotenone on respiration and its point of attack. Exp. Cell Res. 1961, 23:228-237.
17. Lin A.L., Poteet E., Du F., Gourav R.C., Liu R., Wen Y., Bresnen A., Huang S., Fox P.T., Yang S.H., Duong T.Q. Methylene blue as a cerebral metabolic and hemodynamic enhancer. PLoS One 2012, 7:e46585.
18. Liu Z.M., Schmidt K.F., Sicard K.M., Duong T.Q. Imaging oxygen consumption in forepaw somatosensory stimulation in rats under isoflurane anesthesia. Magn. Reson. Med. 2004, 52:277-285.
19. Louters L.L., Dyste S.G., Frieswyk D., Tenharmsel A., Vander Kooy T.O., Walters L., Whalen T. Methylene blue stimulates 2-deoxyglucose uptake in L929 fibroblast cells. Life Sci. 2006, 78:586-591.
20. Mandeville J.B., Marota J.J., Kosofsky B.E., Keltner J.R., Weissleder R., Rosen B.R. Dynamic functional imaging of relative cerebral blood volume during rat forepaw stimulation. Magn. Reson. Med. 1998, 39:615-624.
21. Mandeville J.B., Marota J.J., Ayata C., Moskowitz M.A., Weisskoff R.M., Rosen B.R. MRI measurement of the temporal evolution of relative CMRO2 during rat forepaw stimulation. Magn. Reson. Med. 1999, 42:944-951.
22. Martinez J., Jensen R.A., Vasquez B., McGuiness T., McGaugh J.L. Methylene blue alters retention of inhibitory avoidance responses. Physiol. Psychol. 1978, 6:387-390.
23. Medina D.X., Caccamo A., Oddo S. Methylene blue reduces abeta levels and rescues early cognitive deficit by increasing proteasome activity. Brain Pathol. 2010, 21:140-149.
24. Miclescu A., Basu S., Wiklund L. Methylene blue added to a hypertonic-hyperoncotic solution increases short-term survival in experimental cardiac arrest. Crit. Care Med. 2006, 34:2806-2813.
25. Ogawa S., Lee T.-M., Kay A.R., Tank D.W. Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:9868-9872.
26. Ogawa S., Tank D.W., Menon R., Ellermann J.M., Kim S.-G., Merkle H., Ugurbil K. Intrinsic signal changes accompanying sensory stimulation: functional brain mapping with magnetic resonance imaging. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:5951-5955.
27. O'Leary J.C., Li Q., Marinec P., Blair L.J., Congdon E.E., Johnson A.G., Jinwal U.K., Koren J., Jones J.R., Kraft C., Peters M., Abisambra J.F., Duff K.E., Weeber E.J., Gestwicki J.E., Dickey C.A. Phenothiazine-mediated rescue of cognition in tau transgenic mice requires neuroprotection and reduced soluble tau burden. Mol. Neurodegener. 2010, 5:45.
28. Oz M., Lorke D.E., Petroianu G.A. Methylene blue and Alzheimer's disease. Biochem. Pharmacol. 2009, 78:927-932.
29. Peter C., Hongwan D., Kupfer A., Lauterburg B.H. Pharmacokinetics and organ distribution of intravenous and oral methylene blue. Eur. J. Clin. Pharmacol. 2000, 56:247-250.
30. Riha P.D., Bruchey A.K., Echevarria D.J., Gonzalez-Lima F. Memory facilitation by methylene blue: dose-dependent effect on behavior and brain oxygen consumption. Eur. J. Pharmacol. 2005, 511:151-158.
31. Riha P.D., Rojas J.C., Gonzalez-Lima F. Beneficial network effects of methylene blue in an amnestic model. NeuroImage 2011, 54:2623-2634.
32. Rojas J.C., Bruchey A.K., Gonzalez-Lima F. Neurometabolic mechanisms for memory enhancement and neuroprotection of methylene blue. Prog. Neurobiol. 2012, 96:32-45.
33. Roy C.S., Sherrington C.S. On the regulation of blood supply of the brain. J. Physiol. 1890, 1:85-108.
34. Scheindlin S. Something old. something blue. Mol. Interv. 2008, 8:268-273.
35. Scott A., Hunter F.E. Support of thyroxine-induced swelling of liver mitochondria by generation of high energy intermediates at any one of three sites in electron transport. J. Biol. Chem. 1966, 241:1060-1066.
36. Schmidt K.F., Febo M., Shen Q., Luo F., Sicard K.M., Ferris C.F., Stein E.A., Duong T.Q. Hemodynamic and metabolic changes induced by cocaine in anesthetized rat observed with multimodal functional MRI. Psychopharmacology 2006, 185:479-486.
37. Shen Q., Meng X., Fisher M., Sotak C.H., Duong T.Q. Pixel-by-pixel spatiotemporal progression of focal ischemia derived using quantitative perfusion and diffusion imaging. J. Cereb. Blood Flow Metab. 2003, 23:1479-1488.
38. Shen Q., Fisher M., Sotak C.H., Duong T.Q. Effects of reperfusion on ADC and CBF pixel-by-pixel dynamics in stroke: characterizing tissue fates using quantitative diffusion and perfusion imaging. J Cereb Blood Flow Metab 2004, 24:280-290.
39. Shen Q., Ren H., Bouley J., Fisher M., Duong T.Q. Dynamic tracking of acute ischemic tissue fates using improved unsupervised ISODATA analysis of high-resolution quantitative perfusion and diffusion data. J Cereb Blood Flow and Metab 2004, 24:887-897.
40. Shen Q., Ren H., Cheng H., Fisher M., Duong T.Q. Functional, perfusion and diffusion MRI of acute focal ischemic brain injury. J. Cereb. Blood Flow Metab. 2005, 25:1265-1279.
41. Sicard K., Shen Q., Brevard M.E., Sullivan R., Ferris C.F., King J.A., Duong T.Q. Regional cerebral blood flow and BOLD responses in conscious and anesthetized rats under basal and hypercapnic conditions: implications for functional MRI studies. J Cereb Blood Flow Metab 2003, 23:472-481.
42. Sicard K.M., Duong T.Q. Effects of hypoxia, hyperoxia and hypercapnia on baseline and stimulus-evoked BOLD, CBF and CMRO2 in spontaneously breathing animals. NeuroImage 2005, 25:850-858.
43. Silva A., Lee S.-P., Yang C., Iadecola C., Kim S.-G. Simultaneous BOLD and perfusion functional MRI during forepaw stimulation in rats. J. Cereb. Blood Flow Metab. 1999, 19:871-879.
44. Wen Y., Li W., Poteet E.C., Xie L., Tan C., Yan L.J., Ju X., Liu R., Qian H., Marvin M.A., Goldberg M.S., She H., Mao Z., Simpkins J.W., Yang S.H. Alternative mitochondrial electron transfer as a novel strategy for neuroprotection. J. Biol. Chem. 2011, 286:16504-16515.
45. Wrubel K.M., Riha P.D., Maldonado M.A., McCollum D., Gonzalez-Lima F. The brain metabolic enhancer methylene blue improves discrimination learning in rats. Pharmacol. Biochem. Behav. 2007, 86:712-717.
46. Zhang X., Rojas J.C., Gonzalez-Lima F. Methylene blue prevents neurodegeneration caused by rotenone in the retina. Neurotox. Res. 2006, 9:47-57.